English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background  Hypertension, the most common comorbidity among coronavirus disease 2019 (COVID-19) patients, is accompanied by worse clinical outcomes, but there is lack of evidence about prognostic factors among COVID-19 patients with hypertension. We have come up with some prognostic factors to predict the severity of COVID-19 among hypertensive patients. In addition, epidemiologic, clinical and laboratory differences among COVID-19 patients with and without underlying hypertension were evaluated.    Methods  Medical profiles of 598 COVID-19 cases were analyzed. Patients were divided into two comparative groups according to their positive or negative history of hypertension. Then, epidemiologic, clinical, laboratory and radiological features and also clinical outcomes were compared.    Results  176 (29.4%) patients had underlying hypertension. Diabetes was significantly higher in hypertensive group [72 (40.9%) vs 76 (18%)] ( P -value: 0.001). Cardiovascular and renal disorders were significantly higher in hypertensive patients. ( P -value: 0.001 and 0.013 respectively). In COVID-19 patients with hypertension, severe/critical types were significantly higher. [42(23.8%) vs. 41(9.7%)], ( P -value: 0.012). In the logistic regression model, Body mass index > 25 (OR Adj : 1.8, 95% CI: 1.2 to 2.42;  P -value: 0.027), age over 60 (OR Adj : 1.26, 95% CI: 1.08 to 1.42;  P -value: 0.021), increased hospitalization period (OR Adj : 2.1, 95% CI: 1.24 to 2.97;  P -value: 0.013), type 2 diabetes (OR Adj : 2.22, 95% CI: 1.15 to 3.31; P-value: 0.001) and chronic kidney disease (OR Adj : 1.83, 95% CI: 1.19 to 2.21; P-value: 0.013) were related with progression of COVID-19.    Conclusion  Hypertensive patients with Age > 60-year-old, BMI > 25 Kg/m 2 , CVD, diabetes and chronic kidney disease are associated with poor outcomes in those with COVID-19 infection.

Should all patients with hypertension be worried about developing severe coronavirus disease 2019 (COVID-19)?